InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,955.20
(
0.31%
)
Dow Jones
39,344.79
(
0.00%
)
Brent Oil
85.07
(
-0.40%
)
Bitcoin
57,484.52
(
1.37%
)
Post# of 252526
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 59
Posts 6647
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: genisi post# 98969

Friday, 07/30/2010 3:51:53 AM

Friday, July 30, 2010 3:51:53 AM

Post# of 252526
FDA warns of pneumonia risk with Cubist drug

uly 29 (Reuters) - U.S. health officials warned Thursday about the risk of [a rare type of] pneumonia with Cubist Pharmaceuticals Inc's (CBST.O) flagship antibiotic.

The Food and Drug Administration said patients treated with the intravenous antibiotic Cubicin may develop eosinophilic pneumonia, which causes a potentially fatal accumulation of white blood cells in the lungs.


http://www.reuters.com/article/idCNN2925205620100729?rpc=44
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up